Cargando...
An unusual flare of anti-synthetase syndrome during concurrent trastuzumab therapy given for recurrent breast cancer
We present the case of a patient with relapsing anti-synthetase syndrome (ASS) that may have been triggered by monoclonal antibody trastuzumab therapy given for breast cancer. A 52-year-old female with a history of anti-Jo1-associated ASS went into remission with glucocorticoids and mycophenolate mo...
Gardado en:
| Publicado en: | Eur J Rheumatol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Medical Research and Education Association
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5741342/ https://ncbi.nlm.nih.gov/pubmed/29308284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2017.17036 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|